WASHINGTON, D.C., May 21, 2013 -- The Coalition for the Advancement of Medical Research (CAMR) announced today it is transferring its mission and its assets to the Alliance for Regenerative Medicine (ARM).
Press Releases
WASHINGTON, DC, January 3, 2013 – The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced that 18 ARM members will be presenting at the Biotech Showcase 2013 meeting in San Francisco next week.
WASHINGTON, DC, December 19, 2012 – The Alliance for Regenerative Medicine (ARM) today announced its first Regen Med Investor Day will take place on April 17, 2013. Co-hosted by leading financial firms Burrill & Company, Piper Jaffray and Maxim Group, this one-day meeting will provide institutional, strategic and venture investors’ unique insight into the investment hypothesis for regenerative medicine-based therapeutics and tools.
WASHINGTON, DC, December 18, 2012 – The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced that the third annual State of the Industry Briefing will take place on January 8, 2013 in San Francisco.
WASHINGTON, DEC. 13, 2012 — /PRNewswire/ -- The Alliance for Regenerative Medicine (ARM) today announced the formation of a Tissue Engineering and Biomaterials Committee (TEBC). The TEBC has been established to assemble the companies, academic institutions, and organizations within the Alliance for Regenerative Medicine that develop and commercialize tissue engineered and biomaterial based technologies.
WASHINGTON, DC--(Marketwire - Nov 15, 2012) - The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine community, announces the election of Geoff MacKay, President and Chief Executive Officer (CEO) of Organogenesis Inc., as its next chair and Keith Murphy, Chairman and CEO of Organovo, as Vice-Chair. Ed Field, Chief Operating Officer (COO) of Cytomedix, and Martin McGlynn, President and CEO of StemCells, Inc. were elected to the two other officer positions. Mr.
ARM Co-Authors ‘Practical Regulatory Advice’ Article for Cell-Based Therapies
Agenda to Include Interactive Panels and Case Studies Featuring Key Opinion Leaders
WASHINGTON, DC, Oct 03, 2012 (MARKETWIRE via COMTEX) -- The 2012 Stem Cell Meeting on the Mesa today announced further details of the agenda for its second annual Investor and Partnering Forum. The conference will include 35 corporate presentations, a distinguished plenary session and a series of panel discussions featuring several of the field's key opinion leaders.
WASHINGTON, DC, Aug 21, 2012 (MARKETWIRE via COMTEX) -- The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced that the second annual Investor and Partnering Forum will take place during the Stem Cell Meeting on the Mesa on October 29 and 30, 2012. This meeting gathers the leadership of the regenerative medicine industry including executives from more than 110 ARM member companies and organizations.
WASHINGTON, DC--(Marketwire -06/05/12)- The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced the full agenda for the Clinical Outlooks for Regenerative Medicine meeting. The event will take place on June 19, 2012 at The Starr Center, Schepens Eye Research Institute, 185 Cambridge Street, Boston, MA.
Pages
Featured
Save the Date - October 14 -16, 2013 - for regenerative medicine's top conference bringing together both...
In partnership with the California Institute for Regenerative Medicine (CIRM), ARM is hosting a private,...
ARM's 2013 Annual Report is now available for download. This annual publication provides an...